The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Needle-Free Vaccine Injectors Market Research Report 2024
Synopsis
The global Needle-Free Vaccine Injectors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Needle-Free Vaccine Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Vaccine Injectors.
Report Scope
The Needle-Free Vaccine Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Needle-Free Vaccine Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Vaccine Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antares Pharma, Inc. (U.S.)
INJEX Pharma AG (Germany)
Endo International plc (U.S.)
PharmaJet (U.S)
European Pharma Group (Netherland)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
Valeritas, Inc. (U.S.)
National Medical Products Inc. (U.S.)
PenJet Corporation (U.S)
Crossject SA (France)
Segment by Type
Prefilled Needle-Free Injectors
Fillable Needle-Free Injectors
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Needle-Free Vaccine Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Needle-Free Vaccine Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Needle-Free Vaccine Injectors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Needle-Free Vaccine Injectors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Vaccine Injectors.
Report Scope
The Needle-Free Vaccine Injectors market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Needle-Free Vaccine Injectors market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Vaccine Injectors manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antares Pharma, Inc. (U.S.)
INJEX Pharma AG (Germany)
Endo International plc (U.S.)
PharmaJet (U.S)
European Pharma Group (Netherland)
Bioject Medical Technologies Inc. (U.S)
Medical International Technology, Inc. (U.S)
Valeritas, Inc. (U.S.)
National Medical Products Inc. (U.S.)
PenJet Corporation (U.S)
Crossject SA (France)
Segment by Type
Prefilled Needle-Free Injectors
Fillable Needle-Free Injectors
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Needle-Free Vaccine Injectors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Needle-Free Vaccine Injectors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Needle-Free Vaccine Injectors Market Overview
1.1 Product Overview and Scope of Needle-Free Vaccine Injectors
1.2 Needle-Free Vaccine Injectors Segment by Type
1.2.1 Global Needle-Free Vaccine Injectors Market Value Comparison by Type (2024-2030)
1.2.2 Prefilled Needle-Free Injectors
1.2.3 Fillable Needle-Free Injectors
1.3 Needle-Free Vaccine Injectors Segment by Application
1.3.1 Global Needle-Free Vaccine Injectors Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Needle-Free Vaccine Injectors Market Size Estimates and Forecasts
1.4.1 Global Needle-Free Vaccine Injectors Revenue 2019-2030
1.4.2 Global Needle-Free Vaccine Injectors Sales 2019-2030
1.4.3 Global Needle-Free Vaccine Injectors Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Needle-Free Vaccine Injectors Market Competition by Manufacturers
2.1 Global Needle-Free Vaccine Injectors Sales Market Share by Manufacturers (2019-2024)
2.2 Global Needle-Free Vaccine Injectors Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Needle-Free Vaccine Injectors Average Price by Manufacturers (2019-2024)
2.4 Global Needle-Free Vaccine Injectors Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Needle-Free Vaccine Injectors, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Needle-Free Vaccine Injectors, Product Type & Application
2.7 Needle-Free Vaccine Injectors Market Competitive Situation and Trends
2.7.1 Needle-Free Vaccine Injectors Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Needle-Free Vaccine Injectors Players Market Share by Revenue
2.7.3 Global Needle-Free Vaccine Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Needle-Free Vaccine Injectors Retrospective Market Scenario by Region
3.1 Global Needle-Free Vaccine Injectors Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Needle-Free Vaccine Injectors Global Needle-Free Vaccine Injectors Sales by Region: 2019-2030
3.2.1 Global Needle-Free Vaccine Injectors Sales by Region: 2019-2024
3.2.2 Global Needle-Free Vaccine Injectors Sales by Region: 2025-2030
3.3 Global Needle-Free Vaccine Injectors Global Needle-Free Vaccine Injectors Revenue by Region: 2019-2030
3.3.1 Global Needle-Free Vaccine Injectors Revenue by Region: 2019-2024
3.3.2 Global Needle-Free Vaccine Injectors Revenue by Region: 2025-2030
3.4 North America Needle-Free Vaccine Injectors Market Facts & Figures by Country
3.4.1 North America Needle-Free Vaccine Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Needle-Free Vaccine Injectors Sales by Country (2019-2030)
3.4.3 North America Needle-Free Vaccine Injectors Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Needle-Free Vaccine Injectors Market Facts & Figures by Country
3.5.1 Europe Needle-Free Vaccine Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Needle-Free Vaccine Injectors Sales by Country (2019-2030)
3.5.3 Europe Needle-Free Vaccine Injectors Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-Free Vaccine Injectors Market Facts & Figures by Country
3.6.1 Asia Pacific Needle-Free Vaccine Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Needle-Free Vaccine Injectors Sales by Country (2019-2030)
3.6.3 Asia Pacific Needle-Free Vaccine Injectors Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Needle-Free Vaccine Injectors Market Facts & Figures by Country
3.7.1 Latin America Needle-Free Vaccine Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Needle-Free Vaccine Injectors Sales by Country (2019-2030)
3.7.3 Latin America Needle-Free Vaccine Injectors Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Needle-Free Vaccine Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa Needle-Free Vaccine Injectors Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Needle-Free Vaccine Injectors Sales by Country (2019-2030)
3.8.3 Middle East and Africa Needle-Free Vaccine Injectors Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Needle-Free Vaccine Injectors Sales by Type (2019-2030)
4.1.1 Global Needle-Free Vaccine Injectors Sales by Type (2019-2024)
4.1.2 Global Needle-Free Vaccine Injectors Sales by Type (2025-2030)
4.1.3 Global Needle-Free Vaccine Injectors Sales Market Share by Type (2019-2030)
4.2 Global Needle-Free Vaccine Injectors Revenue by Type (2019-2030)
4.2.1 Global Needle-Free Vaccine Injectors Revenue by Type (2019-2024)
4.2.2 Global Needle-Free Vaccine Injectors Revenue by Type (2025-2030)
4.2.3 Global Needle-Free Vaccine Injectors Revenue Market Share by Type (2019-2030)
4.3 Global Needle-Free Vaccine Injectors Price by Type (2019-2030)
5 Segment by Application
5.1 Global Needle-Free Vaccine Injectors Sales by Application (2019-2030)
5.1.1 Global Needle-Free Vaccine Injectors Sales by Application (2019-2024)
5.1.2 Global Needle-Free Vaccine Injectors Sales by Application (2025-2030)
5.1.3 Global Needle-Free Vaccine Injectors Sales Market Share by Application (2019-2030)
5.2 Global Needle-Free Vaccine Injectors Revenue by Application (2019-2030)
5.2.1 Global Needle-Free Vaccine Injectors Revenue by Application (2019-2024)
5.2.2 Global Needle-Free Vaccine Injectors Revenue by Application (2025-2030)
5.2.3 Global Needle-Free Vaccine Injectors Revenue Market Share by Application (2019-2030)
5.3 Global Needle-Free Vaccine Injectors Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Antares Pharma, Inc. (U.S.)
6.1.1 Antares Pharma, Inc. (U.S.) Corporation Information
6.1.2 Antares Pharma, Inc. (U.S.) Description and Business Overview
6.1.3 Antares Pharma, Inc. (U.S.) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Antares Pharma, Inc. (U.S.) Needle-Free Vaccine Injectors Product Portfolio
6.1.5 Antares Pharma, Inc. (U.S.) Recent Developments/Updates
6.2 INJEX Pharma AG (Germany)
6.2.1 INJEX Pharma AG (Germany) Corporation Information
6.2.2 INJEX Pharma AG (Germany) Description and Business Overview
6.2.3 INJEX Pharma AG (Germany) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.2.4 INJEX Pharma AG (Germany) Needle-Free Vaccine Injectors Product Portfolio
6.2.5 INJEX Pharma AG (Germany) Recent Developments/Updates
6.3 Endo International plc (U.S.)
6.3.1 Endo International plc (U.S.) Corporation Information
6.3.2 Endo International plc (U.S.) Description and Business Overview
6.3.3 Endo International plc (U.S.) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo International plc (U.S.) Needle-Free Vaccine Injectors Product Portfolio
6.3.5 Endo International plc (U.S.) Recent Developments/Updates
6.4 PharmaJet (U.S)
6.4.1 PharmaJet (U.S) Corporation Information
6.4.2 PharmaJet (U.S) Description and Business Overview
6.4.3 PharmaJet (U.S) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 PharmaJet (U.S) Needle-Free Vaccine Injectors Product Portfolio
6.4.5 PharmaJet (U.S) Recent Developments/Updates
6.5 European Pharma Group (Netherland)
6.5.1 European Pharma Group (Netherland) Corporation Information
6.5.2 European Pharma Group (Netherland) Description and Business Overview
6.5.3 European Pharma Group (Netherland) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.5.4 European Pharma Group (Netherland) Needle-Free Vaccine Injectors Product Portfolio
6.5.5 European Pharma Group (Netherland) Recent Developments/Updates
6.6 Bioject Medical Technologies Inc. (U.S)
6.6.1 Bioject Medical Technologies Inc. (U.S) Corporation Information
6.6.2 Bioject Medical Technologies Inc. (U.S) Description and Business Overview
6.6.3 Bioject Medical Technologies Inc. (U.S) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Bioject Medical Technologies Inc. (U.S) Needle-Free Vaccine Injectors Product Portfolio
6.6.5 Bioject Medical Technologies Inc. (U.S) Recent Developments/Updates
6.7 Medical International Technology, Inc. (U.S)
6.6.1 Medical International Technology, Inc. (U.S) Corporation Information
6.6.2 Medical International Technology, Inc. (U.S) Description and Business Overview
6.6.3 Medical International Technology, Inc. (U.S) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Medical International Technology, Inc. (U.S) Needle-Free Vaccine Injectors Product Portfolio
6.7.5 Medical International Technology, Inc. (U.S) Recent Developments/Updates
6.8 Valeritas, Inc. (U.S.)
6.8.1 Valeritas, Inc. (U.S.) Corporation Information
6.8.2 Valeritas, Inc. (U.S.) Description and Business Overview
6.8.3 Valeritas, Inc. (U.S.) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Valeritas, Inc. (U.S.) Needle-Free Vaccine Injectors Product Portfolio
6.8.5 Valeritas, Inc. (U.S.) Recent Developments/Updates
6.9 National Medical Products Inc. (U.S.)
6.9.1 National Medical Products Inc. (U.S.) Corporation Information
6.9.2 National Medical Products Inc. (U.S.) Description and Business Overview
6.9.3 National Medical Products Inc. (U.S.) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.9.4 National Medical Products Inc. (U.S.) Needle-Free Vaccine Injectors Product Portfolio
6.9.5 National Medical Products Inc. (U.S.) Recent Developments/Updates
6.10 PenJet Corporation (U.S)
6.10.1 PenJet Corporation (U.S) Corporation Information
6.10.2 PenJet Corporation (U.S) Description and Business Overview
6.10.3 PenJet Corporation (U.S) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.10.4 PenJet Corporation (U.S) Needle-Free Vaccine Injectors Product Portfolio
6.10.5 PenJet Corporation (U.S) Recent Developments/Updates
6.11 Crossject SA (France)
6.11.1 Crossject SA (France) Corporation Information
6.11.2 Crossject SA (France) Needle-Free Vaccine Injectors Description and Business Overview
6.11.3 Crossject SA (France) Needle-Free Vaccine Injectors Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Crossject SA (France) Needle-Free Vaccine Injectors Product Portfolio
6.11.5 Crossject SA (France) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-Free Vaccine Injectors Industry Chain Analysis
7.2 Needle-Free Vaccine Injectors Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-Free Vaccine Injectors Production Mode & Process
7.4 Needle-Free Vaccine Injectors Sales and Marketing
7.4.1 Needle-Free Vaccine Injectors Sales Channels
7.4.2 Needle-Free Vaccine Injectors Distributors
7.5 Needle-Free Vaccine Injectors Customers
8 Needle-Free Vaccine Injectors Market Dynamics
8.1 Needle-Free Vaccine Injectors Industry Trends
8.2 Needle-Free Vaccine Injectors Market Drivers
8.3 Needle-Free Vaccine Injectors Market Challenges
8.4 Needle-Free Vaccine Injectors Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Needle-Free Vaccine Injectors Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Needle-Free Vaccine Injectors Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Needle-Free Vaccine Injectors Market Competitive Situation by Manufacturers in 2023
Table 4. Global Needle-Free Vaccine Injectors Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Needle-Free Vaccine Injectors Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Needle-Free Vaccine Injectors Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Needle-Free Vaccine Injectors Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Needle-Free Vaccine Injectors Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Needle-Free Vaccine Injectors, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Needle-Free Vaccine Injectors, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Needle-Free Vaccine Injectors, Product Type & Application
Table 12. Global Key Manufacturers of Needle-Free Vaccine Injectors, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Needle-Free Vaccine Injectors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Vaccine Injectors as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Needle-Free Vaccine Injectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Needle-Free Vaccine Injectors Sales by Region (2019-2024) & (K Units)
Table 18. Global Needle-Free Vaccine Injectors Sales Market Share by Region (2019-2024)
Table 19. Global Needle-Free Vaccine Injectors Sales by Region (2025-2030) & (K Units)
Table 20. Global Needle-Free Vaccine Injectors Sales Market Share by Region (2025-2030)
Table 21. Global Needle-Free Vaccine Injectors Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Needle-Free Vaccine Injectors Revenue Market Share by Region (2019-2024)
Table 23. Global Needle-Free Vaccine Injectors Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Needle-Free Vaccine Injectors Revenue Market Share by Region (2025-2030)
Table 25. North America Needle-Free Vaccine Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Needle-Free Vaccine Injectors Sales by Country (2019-2024) & (K Units)
Table 27. North America Needle-Free Vaccine Injectors Sales by Country (2025-2030) & (K Units)
Table 28. North America Needle-Free Vaccine Injectors Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Needle-Free Vaccine Injectors Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Needle-Free Vaccine Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Needle-Free Vaccine Injectors Sales by Country (2019-2024) & (K Units)
Table 32. Europe Needle-Free Vaccine Injectors Sales by Country (2025-2030) & (K Units)
Table 33. Europe Needle-Free Vaccine Injectors Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Needle-Free Vaccine Injectors Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Needle-Free Vaccine Injectors Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Needle-Free Vaccine Injectors Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Needle-Free Vaccine Injectors Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Needle-Free Vaccine Injectors Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Needle-Free Vaccine Injectors Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Needle-Free Vaccine Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Needle-Free Vaccine Injectors Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Needle-Free Vaccine Injectors Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Needle-Free Vaccine Injectors Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Needle-Free Vaccine Injectors Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Needle-Free Vaccine Injectors Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Needle-Free Vaccine Injectors Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Needle-Free Vaccine Injectors Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Needle-Free Vaccine Injectors Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Needle-Free Vaccine Injectors Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Needle-Free Vaccine Injectors Sales (K Units) by Type (2019-2024)
Table 51. Global Needle-Free Vaccine Injectors Sales (K Units) by Type (2025-2030)
Table 52. Global Needle-Free Vaccine Injectors Sales Market Share by Type (2019-2024)
Table 53. Global Needle-Free Vaccine Injectors Sales Market Share by Type (2025-2030)
Table 54. Global Needle-Free Vaccine Injectors Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Needle-Free Vaccine Injectors Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Needle-Free Vaccine Injectors Revenue Market Share by Type (2019-2024)
Table 57. Global Needle-Free Vaccine Injectors Revenue Market Share by Type (2025-2030)
Table 58. Global Needle-Free Vaccine Injectors Price (US$/Unit) by Type (2019-2024)
Table 59. Global Needle-Free Vaccine Injectors Price (US$/Unit) by Type (2025-2030)
Table 60. Global Needle-Free Vaccine Injectors Sales (K Units) by Application (2019-2024)
Table 61. Global Needle-Free Vaccine Injectors Sales (K Units) by Application (2025-2030)
Table 62. Global Needle-Free Vaccine Injectors Sales Market Share by Application (2019-2024)
Table 63. Global Needle-Free Vaccine Injectors Sales Market Share by Application (2025-2030)
Table 64. Global Needle-Free Vaccine Injectors Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Needle-Free Vaccine Injectors Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Needle-Free Vaccine Injectors Revenue Market Share by Application (2019-2024)
Table 67. Global Needle-Free Vaccine Injectors Revenue Market Share by Application (2025-2030)
Table 68. Global Needle-Free Vaccine Injectors Price (US$/Unit) by Application (2019-2024)
Table 69. Global Needle-Free Vaccine Injectors Price (US$/Unit) by Application (2025-2030)
Table 70. Antares Pharma, Inc. (U.S.) Corporation Information
Table 71. Antares Pharma, Inc. (U.S.) Description and Business Overview
Table 72. Antares Pharma, Inc. (U.S.) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Antares Pharma, Inc. (U.S.) Needle-Free Vaccine Injectors Product
Table 74. Antares Pharma, Inc. (U.S.) Recent Developments/Updates
Table 75. INJEX Pharma AG (Germany) Corporation Information
Table 76. INJEX Pharma AG (Germany) Description and Business Overview
Table 77. INJEX Pharma AG (Germany) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. INJEX Pharma AG (Germany) Needle-Free Vaccine Injectors Product
Table 79. INJEX Pharma AG (Germany) Recent Developments/Updates
Table 80. Endo International plc (U.S.) Corporation Information
Table 81. Endo International plc (U.S.) Description and Business Overview
Table 82. Endo International plc (U.S.) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Endo International plc (U.S.) Needle-Free Vaccine Injectors Product
Table 84. Endo International plc (U.S.) Recent Developments/Updates
Table 85. PharmaJet (U.S) Corporation Information
Table 86. PharmaJet (U.S) Description and Business Overview
Table 87. PharmaJet (U.S) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. PharmaJet (U.S) Needle-Free Vaccine Injectors Product
Table 89. PharmaJet (U.S) Recent Developments/Updates
Table 90. European Pharma Group (Netherland) Corporation Information
Table 91. European Pharma Group (Netherland) Description and Business Overview
Table 92. European Pharma Group (Netherland) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. European Pharma Group (Netherland) Needle-Free Vaccine Injectors Product
Table 94. European Pharma Group (Netherland) Recent Developments/Updates
Table 95. Bioject Medical Technologies Inc. (U.S) Corporation Information
Table 96. Bioject Medical Technologies Inc. (U.S) Description and Business Overview
Table 97. Bioject Medical Technologies Inc. (U.S) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Bioject Medical Technologies Inc. (U.S) Needle-Free Vaccine Injectors Product
Table 99. Bioject Medical Technologies Inc. (U.S) Recent Developments/Updates
Table 100. Medical International Technology, Inc. (U.S) Corporation Information
Table 101. Medical International Technology, Inc. (U.S) Description and Business Overview
Table 102. Medical International Technology, Inc. (U.S) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Medical International Technology, Inc. (U.S) Needle-Free Vaccine Injectors Product
Table 104. Medical International Technology, Inc. (U.S) Recent Developments/Updates
Table 105. Valeritas, Inc. (U.S.) Corporation Information
Table 106. Valeritas, Inc. (U.S.) Description and Business Overview
Table 107. Valeritas, Inc. (U.S.) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Valeritas, Inc. (U.S.) Needle-Free Vaccine Injectors Product
Table 109. Valeritas, Inc. (U.S.) Recent Developments/Updates
Table 110. National Medical Products Inc. (U.S.) Corporation Information
Table 111. National Medical Products Inc. (U.S.) Description and Business Overview
Table 112. National Medical Products Inc. (U.S.) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. National Medical Products Inc. (U.S.) Needle-Free Vaccine Injectors Product
Table 114. National Medical Products Inc. (U.S.) Recent Developments/Updates
Table 115. PenJet Corporation (U.S) Corporation Information
Table 116. PenJet Corporation (U.S) Description and Business Overview
Table 117. PenJet Corporation (U.S) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. PenJet Corporation (U.S) Needle-Free Vaccine Injectors Product
Table 119. PenJet Corporation (U.S) Recent Developments/Updates
Table 120. Crossject SA (France) Corporation Information
Table 121. Crossject SA (France) Description and Business Overview
Table 122. Crossject SA (France) Needle-Free Vaccine Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Crossject SA (France) Needle-Free Vaccine Injectors Product
Table 124. Crossject SA (France) Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Needle-Free Vaccine Injectors Distributors List
Table 128. Needle-Free Vaccine Injectors Customers List
Table 129. Needle-Free Vaccine Injectors Market Trends
Table 130. Needle-Free Vaccine Injectors Market Drivers
Table 131. Needle-Free Vaccine Injectors Market Challenges
Table 132. Needle-Free Vaccine Injectors Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Needle-Free Vaccine Injectors
Figure 2. Global Needle-Free Vaccine Injectors Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Needle-Free Vaccine Injectors Market Share by Type in 2023 & 2030
Figure 4. Prefilled Needle-Free Injectors Product Picture
Figure 5. Fillable Needle-Free Injectors Product Picture
Figure 6. Global Needle-Free Vaccine Injectors Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Needle-Free Vaccine Injectors Market Share by Application in 2023 & 2030
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Other
Figure 11. Global Needle-Free Vaccine Injectors Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Needle-Free Vaccine Injectors Market Size (2019-2030) & (US$ Million)
Figure 13. Global Needle-Free Vaccine Injectors Sales (2019-2030) & (K Units)
Figure 14. Global Needle-Free Vaccine Injectors Average Price (US$/Unit) & (2019-2030)
Figure 15. Needle-Free Vaccine Injectors Report Years Considered
Figure 16. Needle-Free Vaccine Injectors Sales Share by Manufacturers in 2023
Figure 17. Global Needle-Free Vaccine Injectors Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Needle-Free Vaccine Injectors Players: Market Share by Revenue in 2023
Figure 19. Needle-Free Vaccine Injectors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Needle-Free Vaccine Injectors Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Needle-Free Vaccine Injectors Sales Market Share by Country (2019-2030)
Figure 22. North America Needle-Free Vaccine Injectors Revenue Market Share by Country (2019-2030)
Figure 23. United States Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Needle-Free Vaccine Injectors Sales Market Share by Country (2019-2030)
Figure 26. Europe Needle-Free Vaccine Injectors Revenue Market Share by Country (2019-2030)
Figure 27. Germany Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Needle-Free Vaccine Injectors Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Needle-Free Vaccine Injectors Revenue Market Share by Region (2019-2030)
Figure 34. China Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Needle-Free Vaccine Injectors Sales Market Share by Country (2019-2030)
Figure 44. Latin America Needle-Free Vaccine Injectors Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Needle-Free Vaccine Injectors Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Needle-Free Vaccine Injectors Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Needle-Free Vaccine Injectors Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Needle-Free Vaccine Injectors by Type (2019-2030)
Figure 54. Global Revenue Market Share of Needle-Free Vaccine Injectors by Type (2019-2030)
Figure 55. Global Needle-Free Vaccine Injectors Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Needle-Free Vaccine Injectors by Application (2019-2030)
Figure 57. Global Revenue Market Share of Needle-Free Vaccine Injectors by Application (2019-2030)
Figure 58. Global Needle-Free Vaccine Injectors Price (US$/Unit) by Application (2019-2030)
Figure 59. Needle-Free Vaccine Injectors Value Chain
Figure 60. Needle-Free Vaccine Injectors Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
